文献速递神经MR

钆对比剂对基于定量合成MRI的髓鞘与脑组织体积估算的影响

Effect of Gadolinium on the Estimation of Myelin and Brain Tissue Volumes Based on Quantitative Synthetic MRI.
PubMed 文献 · AJNR Am J Neuroradiol · 2018-12-27

回顾性分析36例脑转移筛查患者的定量合成MR数据,比较钆对比剂注射前后自动髓鞘与脑组织体积测量。注射后白质体积和髓鞘体积、髓鞘分数显著增加,灰质、脑脊液、脑实质及颅内体积显著减少,T1、T2和质子密度显著降低。结论认为钆对比剂对定量合成MRI自动计算髓鞘和脑组织体积有显著影响,可由T1、T2和质子密度降低解释。

要点

  • 钆对比剂注射后定量合成MRI自动测量的白质体积和髓鞘体积、髓鞘分数显著增加。
  • 注射后灰质、脑脊液、脑实质及颅内体积显著减少,非白质/灰质/脑脊液体积无显著变化。
  • T1、T2和质子密度显著降低,髓鞘部分体积显著增加,可能解释体积测量变化。

核心结论

  • 钆对比剂对定量合成MR成像自动计算髓鞘和脑组织体积有显著影响,可由T1、T2和质子密度降低解释。

研究设计与样本

  • 回顾性分析36例转诊进行脑转移筛查患者的定量合成MR成像数据,比较钆对比剂给药前后的自动髓鞘和脑组织体积测量;17例检出脑转移。

关键影像表现/征象

  • 钆对比剂给药后,有转移和无转移患者白质体积分别增加26.65 mL和29.42 mL,髓鞘体积分别增加10.14 mL和12.46 mL。
  • 钆对比剂给药后,有转移和无转移患者髓鞘分数分别增加0.88%和1.09%。
  • 钆对比剂给药后,有转移和无转移患者灰质体积分别减少36.23 mL和34.49 mL,脑脊液体积分别减少20.77 mL和18.94 mL。
  • 钆对比剂给药后,有转移和无转移患者脑实质体积分别减少6.76 mL和2.84 mL,颅内体积分别减少27.41 mL和21.84 mL。
  • 钆对比剂给药后,有转移和无转移患者T1分别降低51.34 ms和46.84 ms,T2分别降低2.67 ms和4.70 ms,质子密度分别降低1.05%和1.28%,髓鞘部分体积分别增加0.78%和0.75%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The effect of gadolinium on the estimation of myelin has not been reported. The aim of the current study was to investigate the effects of gadolinium on automatic myelin and brain tissue volumetry via quantitative synthetic MR imaging.

MATERIALS AND METHODS: The study included 36 patients who were referred for brain metastases screening, and quantitative synthetic MR imaging data before and after gadolinium-based contrast agent administration were analyzed retrospectively. Brain metastases were detected in 17 patients. WM volume, GM volume, CSF volume, non-WM/GM/CSF volume, myelin volume, brain parenchymal volume, myelin fraction (myelin volume/brain parenchymal volume), and intracranial volume were estimated. T1 and T2 relaxation times, proton density, and myelin partial volume per voxel averaged across the brain parenchyma were also analyzed.

RESULTS: In patients with and without metastases after gadolinium-based contrast agent administration, measurements of WM and myelin volumes, and myelin fraction were significantly increased (+26.65 and +29.42 mL, +10.14 and +12.46 mL, +0.88% and +1.09%, respectively), whereas measurements of GM, CSF, brain parenchymal, and intracranial volumes were significantly decreased (-36.23 and -34.49 mL, -20.77 and -18.94 mL, -6.76 and -2.84 mL, -27.41 and -21.84 mL, respectively). Non-WM/GM/CSF volume did not show a significant change. T1, T2, and proton density were significantly decreased (-51.34 and -46.84 ms, -2.67 and -4.70 ms, -1.05%, and -1.28%, respectively) after gadolinium-based contrast agent administration, whereas measurements of myelin partial volume were significantly increased (+0.78% and +0.75%, respectively).

CONCLUSIONS: Gadolinium had a significant effect on the automatic calculation of myelin and brain tissue volumes using quantitative synthetic MR imaging, which can be explained by decreases in T1, T2, and proton density.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Maekawa T, Hagiwara A, Hori M, et al. Effect of Gadolinium on the Estimation of Myelin and Brain Tissue Volumes Based on Quantitative Synthetic MRI. AJNR Am J Neuroradiol. 2018. PMID: 30591507. doi:10.3174/ajnr.A5921

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。